Vetanova Stock

Vetanova Equity

Delisted

The The Equity of Vetanova (VTNA) as of Aug 17, 2026 is 840,000.00 USD. In the previous year, The Equity was 50,000.00 USD — a change of 1,580.00% (higher).

Equity

840,000.00USD

YoY

1,580.00%

Last updated:

In 2026, Vetanova's equity was 840,000.00 USD, a 1,580.00% increase from the 50,000.00 USD equity in the previous year.

Access this data via the Eulerpool API

Vetanova Stock analysis

What does Vetanova do? Vetanova Inc is a company that specializes in the production of veterinary medicines and has its roots in the animal health industry. It was founded in 2005 by a team of experienced veterinarians with the aim of improving the treatment of pets and livestock through the development of innovative products. Vetanova's business model is based on the manufacturing and marketing of veterinary medicines, as well as the sale of pet food and care products. The company's different divisions include both the development and production of prescription drugs and over-the-counter products, which are sold in specialty stores and online shops. Vetanova has specialized particularly in the development of medicines against infections, parasites, and inflammation. The company relies on a combination of traditional and modern manufacturing processes to bring high-quality products to the market. In addition to manufacturing medicines, Vetanova also offers a variety of products for the care and nutrition of pets. These include dietary supplements, pet care products, and specialized pet food tailored to their needs. As a company dedicated to the quality of its products and the health of animals, Vetanova works closely with veterinarians and breeders to ensure that its products meet high standards. In this regard, Vetanova also strives to intensify collaboration with scientific institutions to improve and further develop the effectiveness of its products. Animal welfare is also an important factor for Vetanova. The company advocates for the protection and well-being of animals and supports projects that help animals in need. In summary, Vetanova is a successful and renowned company that has specialized in the development and production of veterinary medicines since 2005. The company offers a wide range of products, including both prescription and over-the-counter products, targeting both pets and livestock. Vetanova is dedicated to the health of animals and focuses on collaborating with veterinarians and breeders to improve the effectiveness and quality of its products. Animal welfare and sustainability are other important aspects emphasized by Vetanova. Vetanova is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Vetanova's Equity

Vetanova's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vetanova's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vetanova's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vetanova's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vetanova’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vetanova stock

The Equity of Vetanova is 840,000.00 USD in 2026.

The Equity of Vetanova changed from 50,000.00 USD to 840,000.00 USD, representing a 1,580.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Vetanova since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Vetanova historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Vetanova

All Key Metrics — Vetanova